For example, it is believed that inhibitors of ATF4 protein synthesis may help to find new approaches to prevent cancer and that ATF4 may become a novel potential target for the treatment of IBD, mitochondrial dysfunction, and other related diseases (Quirós et al., 2017; Hu et al., 2019). This evidence concerns the gene ATF4 and cancer.